These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

825 related items for PubMed ID: 25219386

  • 1. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.
    J Med Case Rep; 2014 Sep 14; 8():307. PubMed ID: 25219386
    [Abstract] [Full Text] [Related]

  • 2. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS.
    J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535
    [Abstract] [Full Text] [Related]

  • 3. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C, Büttner-Herold M, Bertz S, Schiffer M, Buchholz B.
    BMC Nephrol; 2020 Mar 24; 21(1):104. PubMed ID: 32204691
    [Abstract] [Full Text] [Related]

  • 4. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun 24; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 5. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
    Joseph A, Rafat C, Zafrani L, Mariani-Kurkdjian P, Veyradier A, Hertig A, Rondeau E, Mariotte E, Azoulay E.
    Crit Care Med; 2018 Sep 24; 46(9):e904-e911. PubMed ID: 29979220
    [Abstract] [Full Text] [Related]

  • 6. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H.
    Intern Med; 2018 Jun 01; 57(11):1617-1623. PubMed ID: 29434134
    [Abstract] [Full Text] [Related]

  • 7. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 8. Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome.
    Yamada Y, Abe R, Okano Y, Miyakawa Y.
    Intern Med; 2017 Apr 29; 56(9):1085-1088. PubMed ID: 28458317
    [Abstract] [Full Text] [Related]

  • 9. Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.
    Menne J, Delmas Y, Fakhouri F, Licht C, Lommelé Å, Minetti EE, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.
    BMC Nephrol; 2019 Apr 10; 20(1):125. PubMed ID: 30971227
    [Abstract] [Full Text] [Related]

  • 10. Complement Activation and Thrombotic Microangiopathies.
    Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M.
    Clin J Am Soc Nephrol; 2019 Dec 06; 14(12):1719-1732. PubMed ID: 31694864
    [Abstract] [Full Text] [Related]

  • 11. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD.
    Praxis (Bern 1994); 2016 Mar 30; 105(7):389-96. PubMed ID: 27005733
    [Abstract] [Full Text] [Related]

  • 12. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M, Moran SM, Smith RJ, Ren KYM, Smith GN, Shamseddin MK, Avila-Casado C, Garland JS.
    Kidney Int; 2024 May 30; 105(5):960-970. PubMed ID: 38408703
    [Abstract] [Full Text] [Related]

  • 13. Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls.
    Vaisbich MH, Braga A, Gabrielle M, Bueno C, Piazzon F, Kok F.
    Pediatr Nephrol; 2017 Jun 30; 32(6):1089-1092. PubMed ID: 28210839
    [Abstract] [Full Text] [Related]

  • 14. A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab.
    Puri P, Hanxhiu A, O'Hara DV, Hsu D, Vucak-Dzumhur M.
    BMC Nephrol; 2020 Nov 17; 21(1):488. PubMed ID: 33203373
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report].
    Reis S, Ramos D, Cordinhã C, Gomes C.
    Acta Med Port; 2019 Oct 01; 32(10):673-675. PubMed ID: 31625881
    [Abstract] [Full Text] [Related]

  • 16. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA, Marques MB, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.
    Am J Clin Pathol; 2016 Feb 01; 145(2):158-65. PubMed ID: 27124904
    [Abstract] [Full Text] [Related]

  • 17. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.
    N Engl J Med; 2013 Jun 06; 368(23):2169-81. PubMed ID: 23738544
    [Abstract] [Full Text] [Related]

  • 18. POSTPARTUM RENAL THROMBOTIC MICROANGIOPATHY: A TURN-BASED DIFFERENTIAL DIAGNOSIS.
    Markin L, Shatylovych K.
    Wiad Lek; 2022 Jun 06; 75(1):128-131. PubMed ID: 35092261
    [Abstract] [Full Text] [Related]

  • 19. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
    Abe T, Sasaki A, Ueda T, Miyakawa Y, Ochiai H.
    Medicine (Baltimore); 2017 Feb 06; 96(6):e6056. PubMed ID: 28178155
    [Abstract] [Full Text] [Related]

  • 20. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun 06; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.